Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 7
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
- Hemp Industry
UK Hemp Industry Has Everything It Needs Except the Law
The UK’s industrial hemp sector, and its potential, have been raised in Parliament nearly as many times in the first three months of 2026 as the entirety of 2025.
- Industry Trends
Rescheduling Stalemate Leaves MSOs Facing a Billion Dollar Tax Reckoning
The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now presenting some real-world issues for many of the sector’s largest players.
- Hemp Industry
House Agriculture Committee Advances Farm Bill With No Relief for Hemp Industry
The US House Agriculture Committee has voted to advance the 2026 farm bill without adopting any provisions to delay or repeal the incoming ban on intoxicating hemp.
- CBD Market
UK CBD: A Regulator Finding Its Stride, A Sector Holding Its Breath
The UK’s CBD novel foods programme enters 2026 with its autumn ministerial approval target still nominally intact, but facing increasing pressure on multiple fronts.
- Industry Trends
US Cannabis Rescheduling: A Victory or a Federal Trap?
US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all the oxygen out of the room for the last two years.
- International Regulation
France’s Medical Cannabis Framework: Built for Patients or for Regulators?
The French medical cannabis market is now in the very final stage of decision-making before being implemented nationally, as the HAS presented its draft for the pricing and reimbursement strategy earlier this week.
- Industry Trends
New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban recovery, With a Catch
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners.
- Medical Cannabis
Cannabis Europa Paris 2026: France’s Medical Cannabis Reimbursement Plans Revealed
Today (February 19, 2026), Cannabis Europa returns to the French capital for the first time since 2019 at a critical juncture for the incoming French medical cannabis industry.
- Industry Trends
CRS Report Suggests 280E Could be Unconstitutional for Cannabis Businesses
According to recent analysis from the Congressional Research Service, cannabis businesses may not need to wait for rescheduling to challenge the now-notorious 280E tax burden, suggesting that it may be unconstitutional.
- Investment & Finance
Rescheduling Optimism Fades, Cannabis Stocks Follow
It is now nearly two months since President Donald Trump surprised the global cannabis industry by signing an executive order to drag the highly-anticipated cannabis rescheduling process out of the bureaucratic swamp.
- Medical Cannabis
France’s Long-Awaited Medical Cannabis Reimbursement Framework to Be Revealed Next Week
French authorities will present a first draft of the long-awaited pricing and reimbursement decree for medical cannabis on February 18, marking a critical milestone in the country’s drawn-out transition from pilot programme to permanent framework.
